drugset / Trial / NCT00684671

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

NCT00684671 ↗

Phase 4 Completed 506 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelPrevention

Summary

Only subjects who participated in the primary study will be invited to participate in the extension phase and the challenge dose phase of this study.

Timeline

Start
2008-05-26
Primary completion
2008-11-03
Completion
2008-11-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Engerix-B Vaccine — Intramuscular
Comparator HBVAXPRO Vaccine — Intramuscular
Comparator Havrix Vaccine — Intramuscular
Subject Twinrix Vaccine — Intramuscular
Comparator Vaqta Vaccine — Intramuscular